Endometriosis News and Research

Latest Endometriosis News and Research

Cook Medical unveils its uterine manipulator/injectors at 38th Global Congress of Minimally Invasive Gynecology

Cook Medical unveils its uterine manipulator/injectors at 38th Global Congress of Minimally Invasive Gynecology

EMEA's CHMP recommends approval of Merck's ELONVA

EMEA's CHMP recommends approval of Merck's ELONVA

Soligenix receives $9.4M NIAID grant to develop technology for advancing rapidly acting vaccines

Soligenix receives $9.4M NIAID grant to develop technology for advancing rapidly acting vaccines

Third quarter 2009 financial results announced by Soligenix

Third quarter 2009 financial results announced by Soligenix

Ipsen receives marketing authorization in France for its 6-month sustained-release formulation of Decapeptyl

Ipsen receives marketing authorization in France for its 6-month sustained-release formulation of Decapeptyl

Pfizer and BMP Sunstone team up to promote Depo-Provera, a product for treating endometriosis

Pfizer and BMP Sunstone team up to promote Depo-Provera, a product for treating endometriosis

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Neurocrine Biosciences enters into an amendment to its facility lease agreement

Neurocrine Biosciences enters into an amendment to its facility lease agreement

Repros Therapeutics receives further clarification on the Full Clinical Hold status of Proellex

Repros Therapeutics receives further clarification on the Full Clinical Hold status of Proellex

DOR Biopharma to raise $3.85 million from institutional investors

DOR Biopharma to raise $3.85 million from institutional investors

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

Neurocrine and Kingsbridge Capital sign CEFF agreement

Neurocrine and Kingsbridge Capital sign CEFF agreement

Phthalates & Parabens Profile helps identify exposure levels to chemicals

Phthalates & Parabens Profile helps identify exposure levels to chemicals

DOR's Phase 1/2 clinical trial for prevention of radiation enteritis receives NIH grant

DOR's Phase 1/2 clinical trial for prevention of radiation enteritis receives NIH grant

Securities class action lawsuit filed against Repros Therapeutics

Securities class action lawsuit filed against Repros Therapeutics

Two new da Vinci Si HD Surgical System robots added to Swedish Medical Center

Two new da Vinci Si HD Surgical System robots added to Swedish Medical Center

LUNA surgical procedure did not alleviate chronic pelvic pain in women

LUNA surgical procedure did not alleviate chronic pelvic pain in women

WERF to assess the hidden cost of endometriosis to society and women with the disease

WERF to assess the hidden cost of endometriosis to society and women with the disease